Cargando…
Complement C5 inhibition reverses bleomycin-induced thrombotic microangiopathy
Whether C5 blocking may improve the outcomes of patients developing chemotherapy-induced thrombotic microangiopathy (TMA) remains elusive. Lung fibrosis is a well-known complication of bleomycin, whereas TMAs are very rare (<20 cases described). Here, we report an exceptional case of a male patie...
Autores principales: | Salhi, Sofiane, Ribes, David, Faguer, Stanislas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023184/ https://www.ncbi.nlm.nih.gov/pubmed/33841872 http://dx.doi.org/10.1093/ckj/sfaa101 |
Ejemplares similares
-
Monoclonal gammopathy of renal significance presenting with cryoglobulinaemia type I associated severe thrombotic microangiopathy
por: Hesius, Eva, et al.
Publicado: (2022) -
Radiation nephropathy is associated with a glomerular thrombotic microangiopathy and progression to end-stage kidney disease
por: Bertoni, Isabela, et al.
Publicado: (2023) -
Dobrava hantavirus and coinciding SARS-CoV-2 infection mimicking thrombotic microangiopathy and responding to a single dose of eculizumab
por: Aberger, Simon, et al.
Publicado: (2023) -
Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis–Induced Thrombotic Microangiopathies
por: Gouin, Anna, et al.
Publicado: (2021) -
Postsurgical Thrombotic Microangiopathy and Deregulated Complement
por: van Herpt, Thijs T. W., et al.
Publicado: (2022)